Why the study?
It remains unclear how cardiac contractility modulation affects left ventricular reverse remodeling, decompensated heart failure hospitalizations, and mortality in patients with HFrEF.
Does cardiac contractility modulation improve quality of life, reverse remodeling, and prognosis in patients with HFrEF?
Population
Patients with heart failure with reduced left ventricular ejection fraction (HFrEF)
Design
Review
Authors
Loading...
CCM may improve QoL in HFrEF; leaves open effects on remodeling, hospitalizations, and survival pending further RCTs.
Does cardiac contractility modulation improve quality of life, reverse remodeling, and prognosis in patients with HFrEF?
Cardiac contractility modulation improves quality of life in HFrEF patients but currently lacks RCT evidence for improving LVEF or long-term prognosis.
Chugunov et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: